Latorre A - Search Results

1

Long-term subcutaneous recombinant interleukin-2 as maintenance therapy: biological effects and clinical implications.

Guida M, Abbate I, Casamassima A, Musci MD, Latorre A, Lorusso V, Correale M, De Lena M. Guida M, et al. Among authors: latorre a. Cancer Biother. 1995 Fall;10(3):195-203. doi: 10.1089/cbr.1995.10.195. Cancer Biother. 1995. PMID: 8547958 Clinical Trial.

2

Subcutaneous recombinant interleukin-2 plus chemotherapy with cisplatin and dacarbazine in metastatic melanoma.

Guida M, Latorre A, Mastria A, De Lena M. Guida M, et al. Among authors: latorre a. Eur J Cancer. 1996 Apr;32A(4):730-3. doi: 10.1016/0959-8049(95)00662-1. Eur J Cancer. 1996. PMID: 8695281

3

Revertant and potentiating activity of lonidamine in patients with ovarian cancer previously treated with platinum.

De Lena M, Lorusso V, Bottalico C, Brandi M, De Mitrio A, Catino A, Guida M, Latorre A, Leone B, Vallejo C, Gargano G. De Lena M, et al. Among authors: latorre a. J Clin Oncol. 1997 Oct;15(10):3208-13. doi: 10.1200/JCO.1997.15.10.3208. J Clin Oncol. 1997. PMID: 9336357 Clinical Trial.

4

Mitoxantrone, L-leucovorin and 5-fluorouracil: an effective and well tolerated first-line treatment for advanced breast cancer.

Lorusso V, Mancarella S, Catino A, Brandi M, Paradiso A, Latorre A, Mastria A, De Mitrio A, Guida M, De Lena M. Lorusso V, et al. Among authors: latorre a. Tumori. 1999 Jan-Feb;85(1):60-4. doi: 10.1177/030089169908500113. Tumori. 1999. PMID: 10228500

5

High efficacy of paclitaxel and doxorubicin as first-line therapy in advanced breast cancer: a phase I-II study.

De Lena M, Latorre A, Calabrese P, Catino A, Lorusso V, Mazzei A, Aloe A. De Lena M, et al. Among authors: latorre a. J Chemother. 2000 Aug;12(4):367-73. doi: 10.1179/joc.2000.12.4.367. J Chemother. 2000. PMID: 10949988 Clinical Trial.

6

Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study.

De Lena M, Lorusso V, Latorre A, Fanizza G, Gargano G, Caporusso L, Guida M, Catino A, Crucitta E, Sambiasi D, Mazzei A. De Lena M, et al. Among authors: latorre a. Eur J Cancer. 2001 Feb;37(3):364-8. doi: 10.1016/s0959-8049(00)00400-7. Eur J Cancer. 2001. PMID: 11239758 Clinical Trial.

7

Epithelial ovarian cancer: second and third line chemotherapy (review).

Latorre A, De Lena M, Catino A, Crucitta E, Sambiasi D, Guida M, Misino A, Lorusso V. Latorre A, et al. Int J Oncol. 2002 Jul;21(1):179-86. Int J Oncol. 2002. PMID: 12063566 Review.

8

Amifostine as chemoprotectant in metastatic breast cancer patients treated with doxorubicin.

Catino A, Crucitta E, Latorre A, Sambiasi D, Calabrese P, Lorusso V. Catino A, et al. Among authors: latorre a. Oncol Rep. 2003 Jan-Feb;10(1):163-7. Oncol Rep. 2003. PMID: 12469164

9

Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer.

Lorusso V, Crucitta E, Silvestris N, Catino A, Caporusso L, Mazzei A, Guida M, Latorre A, Sambiasi D, D'Amico C, Schittulli F, Calabrese P, De Lena M. Lorusso V, et al. Among authors: latorre a. Br J Cancer. 2003 Feb 24;88(4):491-5. doi: 10.1038/sj.bjc.6600780. Br J Cancer. 2003. PMID: 12592360 Free PMC article. Clinical Trial.

10

A phase I study of capecitabine in combination with vinorelbine in advanced breast cancer.

Lorusso V, Crucitta E, Silvestris N, Guida M, Misino A, Latorre A, De Lena M. Lorusso V, et al. Among authors: latorre a. Clin Breast Cancer. 2003 Jun;4(2):138-41. doi: 10.3816/cbc.2003.n.019. Clin Breast Cancer. 2003. PMID: 12864942 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

549 results

Search Page

Filters